Global Thalassemia Treatment Market Research Report 2023

Publisher Name :
Date: 20-Jan-2023
No. of pages: 89
Inquire Before Buying

Highlights

The global Thalassemia Treatment market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029, witnessing a CAGR of % during the forecast period 2023-2029. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.

North American market for Thalassemia Treatment is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.

Asia-Pacific market for Thalassemia Treatment is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.

The global market for Thalassemia Treatment in Children and Teenagers is estimated to increase from $ million in 2023 to $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.

The key global companies of Thalassemia Treatment include Novartis, Shire PLC, GlaxoSmithKline, Johnson & Johnson, Merck, Acceleron Pharma, Bellicum Pharmaceuticals, Bluebird Bio and Celgene Corporation, etc. In 2022, the world's top three vendors accounted for approximately % of the revenue.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Thalassemia Treatment, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Thalassemia Treatment.

The Thalassemia Treatment market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Thalassemia Treatment market comprehensively. Regional market sizes, concerning products by type, by application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Thalassemia Treatment companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by type, by application, and by regions.

By Company

- Novartis

- Shire PLC

- GlaxoSmithKline

- Johnson & Johnson

- Merck

- Acceleron Pharma

- Bellicum Pharmaceuticals

- Bluebird Bio

- Celgene Corporation

- Gamida Cell

- Incyte Corporation

- Kiadis Pharma

Segment by Type

- DFO

- DFP

- DFX

- Others

Segment by Application

- Children and Teenagers

- Adults

By Region

- North America

- - United States

- - Canada

- Europe

- - Germany

- - France

- - UK

- - Italy

- - Russia

- - Nordic Countries

- - Rest of Europe

- Asia-Pacific

- - China

- - Japan

- - South Korea

- - Southeast Asia

- - India

- - Australia

- - Rest of Asia

- Latin America

- - Mexico

- - Brazil

- - Rest of Latin America

- Middle East & Africa

- - Turkey

- - Saudi Arabia

- - UAE

- - Rest of MEA

Core Chapters

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Thalassemia Treatment companies' competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 11: Provides profiles of key players, introducing the basic situation of the key companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.

Chapter 12: The main points and conclusions of the report.

Global Thalassemia Treatment Market Research Report 2023

Table of Contents
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Thalassemia Treatment Market Size Growth Rate by Type: 2018 VS 2022 VS 2029
1.2.2 DFO
1.2.3 DFP
1.2.4 DFX
1.2.5 Others
1.3 Market by Application
1.3.1 Global Thalassemia Treatment Market Growth by Application: 2018 VS 2022 VS 2029
1.3.2 Children and Teenagers
1.3.3 Adults
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Thalassemia Treatment Market Perspective (2018-2029)
2.2 Thalassemia Treatment Growth Trends by Region
2.2.1 Global Thalassemia Treatment Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 Thalassemia Treatment Historic Market Size by Region (2018-2023)
2.2.3 Thalassemia Treatment Forecasted Market Size by Region (2024-2029)
2.3 Thalassemia Treatment Market Dynamics
2.3.1 Thalassemia Treatment Industry Trends
2.3.2 Thalassemia Treatment Market Drivers
2.3.3 Thalassemia Treatment Market Challenges
2.3.4 Thalassemia Treatment Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Thalassemia Treatment Players by Revenue
3.1.1 Global Top Thalassemia Treatment Players by Revenue (2018-2023)
3.1.2 Global Thalassemia Treatment Revenue Market Share by Players (2018-2023)
3.2 Global Thalassemia Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Thalassemia Treatment Revenue
3.4 Global Thalassemia Treatment Market Concentration Ratio
3.4.1 Global Thalassemia Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Thalassemia Treatment Revenue in 2022
3.5 Thalassemia Treatment Key Players Head office and Area Served
3.6 Key Players Thalassemia Treatment Product Solution and Service
3.7 Date of Enter into Thalassemia Treatment Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Thalassemia Treatment Breakdown Data by Type
4.1 Global Thalassemia Treatment Historic Market Size by Type (2018-2023)
4.2 Global Thalassemia Treatment Forecasted Market Size by Type (2024-2029)
5 Thalassemia Treatment Breakdown Data by Application
5.1 Global Thalassemia Treatment Historic Market Size by Application (2018-2023)
5.2 Global Thalassemia Treatment Forecasted Market Size by Application (2024-2029)
6 North America
6.1 North America Thalassemia Treatment Market Size (2018-2029)
6.2 North America Thalassemia Treatment Market Growth Rate by Country: 2018 VS 2022 VS 2029
6.3 North America Thalassemia Treatment Market Size by Country (2018-2023)
6.4 North America Thalassemia Treatment Market Size by Country (2024-2029)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Thalassemia Treatment Market Size (2018-2029)
7.2 Europe Thalassemia Treatment Market Growth Rate by Country: 2018 VS 2022 VS 2029
7.3 Europe Thalassemia Treatment Market Size by Country (2018-2023)
7.4 Europe Thalassemia Treatment Market Size by Country (2024-2029)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Thalassemia Treatment Market Size (2018-2029)
8.2 Asia-Pacific Thalassemia Treatment Market Growth Rate by Region: 2018 VS 2022 VS 2029
8.3 Asia-Pacific Thalassemia Treatment Market Size by Region (2018-2023)
8.4 Asia-Pacific Thalassemia Treatment Market Size by Region (2024-2029)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Thalassemia Treatment Market Size (2018-2029)
9.2 Latin America Thalassemia Treatment Market Growth Rate by Country: 2018 VS 2022 VS 2029
9.3 Latin America Thalassemia Treatment Market Size by Country (2018-2023)
9.4 Latin America Thalassemia Treatment Market Size by Country (2024-2029)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Thalassemia Treatment Market Size (2018-2029)
10.2 Middle East & Africa Thalassemia Treatment Market Growth Rate by Country: 2018 VS 2022 VS 2029
10.3 Middle East & Africa Thalassemia Treatment Market Size by Country (2018-2023)
10.4 Middle East & Africa Thalassemia Treatment Market Size by Country (2024-2029)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Novartis
11.1.1 Novartis Company Detail
11.1.2 Novartis Business Overview
11.1.3 Novartis Thalassemia Treatment Introduction
11.1.4 Novartis Revenue in Thalassemia Treatment Business (2018-2023)
11.1.5 Novartis Recent Development
11.2 Shire PLC
11.2.1 Shire PLC Company Detail
11.2.2 Shire PLC Business Overview
11.2.3 Shire PLC Thalassemia Treatment Introduction
11.2.4 Shire PLC Revenue in Thalassemia Treatment Business (2018-2023)
11.2.5 Shire PLC Recent Development
11.3 GlaxoSmithKline
11.3.1 GlaxoSmithKline Company Detail
11.3.2 GlaxoSmithKline Business Overview
11.3.3 GlaxoSmithKline Thalassemia Treatment Introduction
11.3.4 GlaxoSmithKline Revenue in Thalassemia Treatment Business (2018-2023)
11.3.5 GlaxoSmithKline Recent Development
11.4 Johnson & Johnson
11.4.1 Johnson & Johnson Company Detail
11.4.2 Johnson & Johnson Business Overview
11.4.3 Johnson & Johnson Thalassemia Treatment Introduction
11.4.4 Johnson & Johnson Revenue in Thalassemia Treatment Business (2018-2023)
11.4.5 Johnson & Johnson Recent Development
11.5 Merck
11.5.1 Merck Company Detail
11.5.2 Merck Business Overview
11.5.3 Merck Thalassemia Treatment Introduction
11.5.4 Merck Revenue in Thalassemia Treatment Business (2018-2023)
11.5.5 Merck Recent Development
11.6 Acceleron Pharma
11.6.1 Acceleron Pharma Company Detail
11.6.2 Acceleron Pharma Business Overview
11.6.3 Acceleron Pharma Thalassemia Treatment Introduction
11.6.4 Acceleron Pharma Revenue in Thalassemia Treatment Business (2018-2023)
11.6.5 Acceleron Pharma Recent Development
11.7 Bellicum Pharmaceuticals
11.7.1 Bellicum Pharmaceuticals Company Detail
11.7.2 Bellicum Pharmaceuticals Business Overview
11.7.3 Bellicum Pharmaceuticals Thalassemia Treatment Introduction
11.7.4 Bellicum Pharmaceuticals Revenue in Thalassemia Treatment Business (2018-2023)
11.7.5 Bellicum Pharmaceuticals Recent Development
11.8 Bluebird Bio
11.8.1 Bluebird Bio Company Detail
11.8.2 Bluebird Bio Business Overview
11.8.3 Bluebird Bio Thalassemia Treatment Introduction
11.8.4 Bluebird Bio Revenue in Thalassemia Treatment Business (2018-2023)
11.8.5 Bluebird Bio Recent Development
11.9 Celgene Corporation
11.9.1 Celgene Corporation Company Detail
11.9.2 Celgene Corporation Business Overview
11.9.3 Celgene Corporation Thalassemia Treatment Introduction
11.9.4 Celgene Corporation Revenue in Thalassemia Treatment Business (2018-2023)
11.9.5 Celgene Corporation Recent Development
11.10 Gamida Cell
11.10.1 Gamida Cell Company Detail
11.10.2 Gamida Cell Business Overview
11.10.3 Gamida Cell Thalassemia Treatment Introduction
11.10.4 Gamida Cell Revenue in Thalassemia Treatment Business (2018-2023)
11.10.5 Gamida Cell Recent Development
11.11 Incyte Corporation
11.11.1 Incyte Corporation Company Detail
11.11.2 Incyte Corporation Business Overview
11.11.3 Incyte Corporation Thalassemia Treatment Introduction
11.11.4 Incyte Corporation Revenue in Thalassemia Treatment Business (2018-2023)
11.11.5 Incyte Corporation Recent Development
11.12 Kiadis Pharma
11.12.1 Kiadis Pharma Company Detail
11.12.2 Kiadis Pharma Business Overview
11.12.3 Kiadis Pharma Thalassemia Treatment Introduction
11.12.4 Kiadis Pharma Revenue in Thalassemia Treatment Business (2018-2023)
11.12.5 Kiadis Pharma Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of Tables
Table 1. Global Thalassemia Treatment Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2029
Table 2. Key Players of DFO
Table 3. Key Players of DFP
Table 4. Key Players of DFX
Table 5. Key Players of Others
Table 6. Global Thalassemia Treatment Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2029
Table 7. Global Thalassemia Treatment Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Table 8. Global Thalassemia Treatment Market Size by Region (2018-2023) & (US$ Million)
Table 9. Global Thalassemia Treatment Market Share by Region (2018-2023)
Table 10. Global Thalassemia Treatment Forecasted Market Size by Region (2024-2029) & (US$ Million)
Table 11. Global Thalassemia Treatment Market Share by Region (2024-2029)
Table 12. Thalassemia Treatment Market Trends
Table 13. Thalassemia Treatment Market Drivers
Table 14. Thalassemia Treatment Market Challenges
Table 15. Thalassemia Treatment Market Restraints
Table 16. Global Thalassemia Treatment Revenue by Players (2018-2023) & (US$ Million)
Table 17. Global Thalassemia Treatment Market Share by Players (2018-2023)
Table 18. Global Top Thalassemia Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Thalassemia Treatment as of 2022)
Table 19. Ranking of Global Top Thalassemia Treatment Companies by Revenue (US$ Million) in 2022
Table 20. Global 5 Largest Players Market Share by Thalassemia Treatment Revenue (CR5 and HHI) & (2018-2023)
Table 21. Key Players Headquarters and Area Served
Table 22. Key Players Thalassemia Treatment Product Solution and Service
Table 23. Date of Enter into Thalassemia Treatment Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Thalassemia Treatment Market Size by Type (2018-2023) & (US$ Million)
Table 26. Global Thalassemia Treatment Revenue Market Share by Type (2018-2023)
Table 27. Global Thalassemia Treatment Forecasted Market Size by Type (2024-2029) & (US$ Million)
Table 28. Global Thalassemia Treatment Revenue Market Share by Type (2024-2029)
Table 29. Global Thalassemia Treatment Market Size by Application (2018-2023) & (US$ Million)
Table 30. Global Thalassemia Treatment Revenue Market Share by Application (2018-2023)
Table 31. Global Thalassemia Treatment Forecasted Market Size by Application (2024-2029) & (US$ Million)
Table 32. Global Thalassemia Treatment Revenue Market Share by Application (2024-2029)
Table 33. North America Thalassemia Treatment Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 34. North America Thalassemia Treatment Market Size by Country (2018-2023) & (US$ Million)
Table 35. North America Thalassemia Treatment Market Size by Country (2024-2029) & (US$ Million)
Table 36. Europe Thalassemia Treatment Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 37. Europe Thalassemia Treatment Market Size by Country (2018-2023) & (US$ Million)
Table 38. Europe Thalassemia Treatment Market Size by Country (2024-2029) & (US$ Million)
Table 39. Asia-Pacific Thalassemia Treatment Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2029
Table 40. Asia-Pacific Thalassemia Treatment Market Size by Region (2018-2023) & (US$ Million)
Table 41. Asia-Pacific Thalassemia Treatment Market Size by Region (2024-2029) & (US$ Million)
Table 42. Latin America Thalassemia Treatment Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 43. Latin America Thalassemia Treatment Market Size by Country (2018-2023) & (US$ Million)
Table 44. Latin America Thalassemia Treatment Market Size by Country (2024-2029) & (US$ Million)
Table 45. Middle East & Africa Thalassemia Treatment Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 46. Middle East & Africa Thalassemia Treatment Market Size by Country (2018-2023) & (US$ Million)
Table 47. Middle East & Africa Thalassemia Treatment Market Size by Country (2024-2029) & (US$ Million)
Table 48. Novartis Company Detail
Table 49. Novartis Business Overview
Table 50. Novartis Thalassemia Treatment Product
Table 51. Novartis Revenue in Thalassemia Treatment Business (2018-2023) & (US$ Million)
Table 52. Novartis Recent Development
Table 53. Shire PLC Company Detail
Table 54. Shire PLC Business Overview
Table 55. Shire PLC Thalassemia Treatment Product
Table 56. Shire PLC Revenue in Thalassemia Treatment Business (2018-2023) & (US$ Million)
Table 57. Shire PLC Recent Development
Table 58. GlaxoSmithKline Company Detail
Table 59. GlaxoSmithKline Business Overview
Table 60. GlaxoSmithKline Thalassemia Treatment Product
Table 61. GlaxoSmithKline Revenue in Thalassemia Treatment Business (2018-2023) & (US$ Million)
Table 62. GlaxoSmithKline Recent Development
Table 63. Johnson & Johnson Company Detail
Table 64. Johnson & Johnson Business Overview
Table 65. Johnson & Johnson Thalassemia Treatment Product
Table 66. Johnson & Johnson Revenue in Thalassemia Treatment Business (2018-2023) & (US$ Million)
Table 67. Johnson & Johnson Recent Development
Table 68. Merck Company Detail
Table 69. Merck Business Overview
Table 70. Merck Thalassemia Treatment Product
Table 71. Merck Revenue in Thalassemia Treatment Business (2018-2023) & (US$ Million)
Table 72. Merck Recent Development
Table 73. Acceleron Pharma Company Detail
Table 74. Acceleron Pharma Business Overview
Table 75. Acceleron Pharma Thalassemia Treatment Product
Table 76. Acceleron Pharma Revenue in Thalassemia Treatment Business (2018-2023) & (US$ Million)
Table 77. Acceleron Pharma Recent Development
Table 78. Bellicum Pharmaceuticals Company Detail
Table 79. Bellicum Pharmaceuticals Business Overview
Table 80. Bellicum Pharmaceuticals Thalassemia Treatment Product
Table 81. Bellicum Pharmaceuticals Revenue in Thalassemia Treatment Business (2018-2023) & (US$ Million)
Table 82. Bellicum Pharmaceuticals Recent Development
Table 83. Bluebird Bio Company Detail
Table 84. Bluebird Bio Business Overview
Table 85. Bluebird Bio Thalassemia Treatment Product
Table 86. Bluebird Bio Revenue in Thalassemia Treatment Business (2018-2023) & (US$ Million)
Table 87. Bluebird Bio Recent Development
Table 88. Celgene Corporation Company Detail
Table 89. Celgene Corporation Business Overview
Table 90. Celgene Corporation Thalassemia Treatment Product
Table 91. Celgene Corporation Revenue in Thalassemia Treatment Business (2018-2023) & (US$ Million)
Table 92. Celgene Corporation Recent Development
Table 93. Gamida Cell Company Detail
Table 94. Gamida Cell Business Overview
Table 95. Gamida Cell Thalassemia Treatment Product
Table 96. Gamida Cell Revenue in Thalassemia Treatment Business (2018-2023) & (US$ Million)
Table 97. Gamida Cell Recent Development
Table 98. Incyte Corporation Company Detail
Table 99. Incyte Corporation Business Overview
Table 100. Incyte Corporation Thalassemia Treatment Product
Table 101. Incyte Corporation Revenue in Thalassemia Treatment Business (2018-2023) & (US$ Million)
Table 102. Incyte Corporation Recent Development
Table 103. Kiadis Pharma Company Detail
Table 104. Kiadis Pharma Business Overview
Table 105. Kiadis Pharma Thalassemia Treatment Product
Table 106. Kiadis Pharma Revenue in Thalassemia Treatment Business (2018-2023) & (US$ Million)
Table 107. Kiadis Pharma Recent Development
Table 108. Research Programs/Design for This Report
Table 109. Key Data Information from Secondary Sources
Table 110. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Thalassemia Treatment Market Size Comparison by Type (2023-2029) & (US$ Million)
Figure 2. Global Thalassemia Treatment Market Share by Type: 2022 VS 2029
Figure 3. DFO Features
Figure 4. DFP Features
Figure 5. DFX Features
Figure 6. Others Features
Figure 7. Global Thalassemia Treatment Market Size Comparison by Application (2023-2029) & (US$ Million)
Figure 8. Global Thalassemia Treatment Market Share by Application: 2022 VS 2029
Figure 9. Children and Teenagers Case Studies
Figure 10. Adults Case Studies
Figure 11. Thalassemia Treatment Report Years Considered
Figure 12. Global Thalassemia Treatment Market Size (US$ Million), Year-over-Year: 2018-2029
Figure 13. Global Thalassemia Treatment Market Size, (US$ Million), 2018 VS 2022 VS 2029
Figure 14. Global Thalassemia Treatment Market Share by Region: 2022 VS 2029
Figure 15. Global Thalassemia Treatment Market Share by Players in 2022
Figure 16. Global Top Thalassemia Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Thalassemia Treatment as of 2022)
Figure 17. The Top 10 and 5 Players Market Share by Thalassemia Treatment Revenue in 2022
Figure 18. North America Thalassemia Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 19. North America Thalassemia Treatment Market Share by Country (2018-2029)
Figure 20. United States Thalassemia Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 21. Canada Thalassemia Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 22. Europe Thalassemia Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 23. Europe Thalassemia Treatment Market Share by Country (2018-2029)
Figure 24. Germany Thalassemia Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 25. France Thalassemia Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 26. U.K. Thalassemia Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 27. Italy Thalassemia Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 28. Russia Thalassemia Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 29. Nordic Countries Thalassemia Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 30. Asia-Pacific Thalassemia Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 31. Asia-Pacific Thalassemia Treatment Market Share by Region (2018-2029)
Figure 32. China Thalassemia Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 33. Japan Thalassemia Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 34. South Korea Thalassemia Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 35. Southeast Asia Thalassemia Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 36. India Thalassemia Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 37. Australia Thalassemia Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 38. Latin America Thalassemia Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 39. Latin America Thalassemia Treatment Market Share by Country (2018-2029)
Figure 40. Mexico Thalassemia Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 41. Brazil Thalassemia Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 42. Middle East & Africa Thalassemia Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 43. Middle East & Africa Thalassemia Treatment Market Share by Country (2018-2029)
Figure 44. Turkey Thalassemia Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 45. Saudi Arabia Thalassemia Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 46. Novartis Revenue Growth Rate in Thalassemia Treatment Business (2018-2023)
Figure 47. Shire PLC Revenue Growth Rate in Thalassemia Treatment Business (2018-2023)
Figure 48. GlaxoSmithKline Revenue Growth Rate in Thalassemia Treatment Business (2018-2023)
Figure 49. Johnson & Johnson Revenue Growth Rate in Thalassemia Treatment Business (2018-2023)
Figure 50. Merck Revenue Growth Rate in Thalassemia Treatment Business (2018-2023)
Figure 51. Acceleron Pharma Revenue Growth Rate in Thalassemia Treatment Business (2018-2023)
Figure 52. Bellicum Pharmaceuticals Revenue Growth Rate in Thalassemia Treatment Business (2018-2023)
Figure 53. Bluebird Bio Revenue Growth Rate in Thalassemia Treatment Business (2018-2023)
Figure 54. Celgene Corporation Revenue Growth Rate in Thalassemia Treatment Business (2018-2023)
Figure 55. Gamida Cell Revenue Growth Rate in Thalassemia Treatment Business (2018-2023)
Figure 56. Incyte Corporation Revenue Growth Rate in Thalassemia Treatment Business (2018-2023)
Figure 57. Kiadis Pharma Revenue Growth Rate in Thalassemia Treatment Business (2018-2023)
Figure 58. Bottom-up and Top-down Approaches for This Report
Figure 59. Data Triangulation
Figure 60. Key Executives Interviewed
  • Global Family Asthma Management Product Market Research Report 2023
    Published: 24-Jan-2023        Price: US 2900 Onwards        Pages: 86
    Highlights The global Family Asthma Management Product market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029, witnessing a CAGR of % during the forecast period 2023-2029. The influence of COVID-19 and the Netherlands-Ukraine War were considered while estimating market sizes. North American market for Family Asthma Management Product is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast perio......
  • Global Asthma Reliever (Rescue) Medications Market Research Report 2023
    Published: 24-Jan-2023        Price: US 2900 Onwards        Pages: 93
    Highlights The global Asthma Reliever (Rescue) Medications market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029, witnessing a CAGR of % during the forecast period 2023-2029. The influence of COVID-19 and the Netherlands-Ukraine War were considered while estimating market sizes. North American market for Asthma Reliever (Rescue) Medications is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the foreca......
  • Global Colloidal Bismuth Pectin Preparations Market Research Report 2023
    Published: 24-Jan-2023        Price: US 2900 Onwards        Pages: 85
    Highlights The global Colloidal Bismuth Pectin Preparations market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029, witnessing a CAGR of % during the forecast period 2023-2029. The influence of COVID-19 and the Netherlands-Ukraine War were considered while estimating market sizes. North American market for Colloidal Bismuth Pectin Preparations is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the fore......
  • Global RNase Inhibitor Market Research Report 2023
    Published: 24-Jan-2023        Price: US 2900 Onwards        Pages: 95
    Highlights The global RNase Inhibitor market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029, witnessing a CAGR of % during the forecast period 2023-2029. The influence of COVID-19 and the Netherlands-Ukraine War were considered while estimating market sizes. North American market for RNase Inhibitor is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029. Asi......
  • Global PD-1 and PD-L1 Monoclonal Antibody Market Research Report 2023
    Published: 24-Jan-2023        Price: US 2900 Onwards        Pages: 96
    Highlights The global PD-1 and PD-L1 Monoclonal Antibody market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029, witnessing a CAGR of % during the forecast period 2023-2029. The influence of COVID-19 and the Netherlands-Ukraine War were considered while estimating market sizes. North American market for PD-1 and PD-L1 Monoclonal Antibody is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast p......
  • Global Orally Fast Dissolving Films (OFDFs) Market Research Report 2023
    Published: 24-Jan-2023        Price: US 2900 Onwards        Pages: 106
    Orally fast dissolving films (OFDFs) have been introduced in the market recently as they provide convenience and ease of use over other dosage forms such as orally disintegrating tablets. This technology evolved over the past few years from the confection and oral care markets in the form of breath strips and became a novel and widely accepted form by consumers, so OFDFs are gaining the interest of large number of pharmaceutical industries. Highlights The global Orally Fast Dissolv......
  • Global Orally Disintegrating Films (ODFs) Market Research Report 2023
    Published: 24-Jan-2023        Price: US 2900 Onwards        Pages: 101
    Orally disintegrating films can be produced with different polymers, which is the main responsible for properties such as disintegration time and mucoadhesiveness, aiming at controlled and more effective release of the active compounds. Highlights The global Orally Disintegrating Films (ODFs) market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029, witnessing a CAGR of % during the forecast period 2023-2029. The influence of COVID-19 and the Netherl......
  • Global Orally Dissolving Strips Market Research Report 2023
    Published: 24-Jan-2023        Price: US 2900 Onwards        Pages: 101
    Oral Dissolving Film in this report. Highlights The global Orally Dissolving Strips market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029, witnessing a CAGR of % during the forecast period 2023-2029. The influence of COVID-19 and the Netherlands-Ukraine War were considered while estimating market sizes. North American market for Orally Dissolving Strips is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of......
  • Global Oral Films Market Research Report 2023
    Published: 24-Jan-2023        Price: US 2900 Onwards        Pages: 107
    Oral films, a promising novel drug delivery system, are a strip of single or multilayered, mucoadhesive or non-mucoadhesive, thin polymeric films that are intended to deliver active therapeutic moieties either locally or systemically in oral cavity through sublingual, buccal, palatal, or gastrointestinal absorption. Highlights The global Oral Films market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029, witnessing a CAGR of % during the forecast pe......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs